Electromembrane extraction (EME) coupled with high performance liquid chromatography and ultraviolet detection was developed for determination of amphetamine-type stimulants in human urine samples. Amphetamines migrated from 3 mL of different human urine matrices, through a thin layer of 2-nitrophenyl octyl ether (NPOE) containing 15% tris-(2-ethylhexyl) phosphate (TEHP) immobilized in the pores of a porous hollow fiber, and into a 15 μL acidic aqueous acceptor solution present inside the lumen of the fiber. Equilibrium extraction conditions were obtained after 7 min of operation. Experimental design and response surface methodology (RSM) were used for optimization of EME parameters. Under optimal conditions, amphetamines were effectively extracted with recoveries in the range of 54-70%, which corresponded to preconcentration factors in the range of 108-140. The calibration curves were investigated in the range of 0-7 μg mL(-1) and good linearity was achieved with a coefficient of estimation better than 0.991. Detection limits and inter-day precision (n=3) were less than 0.01 μg mL(-1) and 11.2%, respectively.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.chroma.2011.05.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy of transcutaneous electrical acupoint stimulation for immunological non-responder in HIV/AIDS combined with amphetamine abuse: study protocol for a randomized controlled trial.
BMC Complement Med Ther
December 2024
School of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Background: Amphetamine-type stimulant (ATS) abuse is strongly associated with an elevated risk of HIV infection and transmission. Antiretroviral therapy (ART) serves as the primary approach for managing HIV infection and AIDS progression. However, ATS abuse diminishes the efficacy of ART in HIV/AIDS patients, amplifying the vulnerability to immunological non-response (INR) and ultimately increasing the incidence rate and mortality of opportunistic infections.
View Article and Find Full Text PDFIs Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis.
J Addict Med
November 2024
From the Department of Psychiatry and Addictology, Université de Montréal, Montréal, Québec, Canada (GB, CM, HS, AM, LE, SD, DJ-A); Research Centre, Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada (GB, CM, HS, AM, LE, SD, L-CJ, DJ-A); Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada (DZ, SD, L-CJ); and Departement of Family Medicine and Emergency Medicine, Université de Montréal, Montréal, Québec, Canada (L-CJ).
Article Synopsis
- A systematic review and meta-analysis were conducted to evaluate the effectiveness and safety of naltrexone as a treatment for amphetamine-type stimulant use disorder (ATSUD) using data from several medical databases.
- Five randomized placebo-controlled trials involving 419 participants were analyzed, showing no significant difference in outcomes such as reductions in stimulant use, treatment retention, or cravings between naltrexone and placebo groups.
- The study concluded that there is insufficient evidence to support the use of naltrexone alone for treating ATSUD, highlighting the need for more research to find effective pharmacotherapies alongside psychosocial treatments.
Patterns and Characteristics of Amphetamine-type Stimulant Use in a North-eastern State of India: A Cross-sectional Study.
Indian J Psychol Med
April 2024
Indian Drug Users Forum, New Delhi, India.
Article Synopsis
- This study investigates the patterns of amphetamine-type stimulant (ATS) use and high-risk behaviors among adults in Manipur, India, revealing that the majority of users engage in daily use and dependence on substances.
- Most participants reported significant health issues related to ATS, including a tendency to inject drugs and risky sexual behavior, such as unprotected sex.
- The findings indicate a need for targeted strategies in India to address and reduce ATS use and its associated physical and psychological consequences.
Chemsex and Beyond: A Study of Factors Associated with Substance Use Among Men Who Have Sex with Men and Transgender Women in Southern Vietnam to Develop Informed HIV and STI Prevention and Intervention Programs.
Indian J Psychol Med
July 2024
National Drug Dependence Treatment Center and Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Article Synopsis
- Amphetamine-type stimulant (ATS) use is a significant public health issue among men who have sex with men (MSM) and transgender women (TGW) globally, including Vietnam.
- A study of 1000 MSM and TGW in southern Vietnam found that over 50% had used ATS in the last three months, with higher usage linked to transactional sex activities.
- The research indicates that certain sexual behaviors associated with ATS use can heighten the risk of HIV transmission in these populations.
Artificial intelligence-based drug repurposing with electronic health record clinical corroboration: A case for ketamine as a potential treatment for amphetamine-type stimulant use disorder.
Addiction
November 2024
Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Article Synopsis
- Amphetamine-type stimulants are widely used illicit drugs, and there's currently no FDA-approved treatment for related disorders, prompting researchers to explore repurposing existing drugs, particularly through AI models.
- The study identified ketamine as a promising candidate for treating amphetamine-type stimulant use disorders and conducted research using electronic health records to assess its effectiveness.
- Results indicated that ketamine was associated with a higher rate of remission in patients with amphetamine-type stimulant use disorders compared to other treatments, targeting specific neurological pathways linked to addiction.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!